Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interpretable PROTAC Degradation Prediction With Structure-Informed Deep Ternary Attention Framework. | Adv Sci (Weinh) | 2025 | 41026144 | PubTator, text mining | PubMed |
| Prevalence of loss-of-function, gain-of-function and dominant-negative mechanisms across genetic disease phenotypes. | Nat Commun | 2025 | 40998763 | PubTator, text mining | PubMed |
| Characterization of the autophagic N-degron pathway and monitoring its chemical modulation for therapeutic development. | Methods Enzymol | 2025 | 40992839 | PubTator, text mining | PubMed |
| Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus. | PLoS One | 2025 | 40991629 | PubTator, text mining | PubMed |
| UPS delivers apolarity and senescence to HSCs. | Blood | 2025 | 40965939 | PubTator, text mining | PubMed |
| Technical requirements and optimization strategies for home-based teleradiology workstations: a review article. | Insights Imaging | 2025 | 40965740 | PubTator, text mining | PubMed |
| The study of biosafety risk identification and analysis for facilities in biosafety level 3 laboratories. | Front Cell Infect Microbiol | 2025 | 40937440 | PubTator, text mining | PubMed |
| TRIM2 inhibits apoptosis by ubiquitinating BNIP3 to protect the intestine against ischemia-reperfusion injury in mice. | Commun Biol | 2025 | 40883557 | PubTator, text mining | PubMed |
| UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation. | Nat Commun | 2025 | 40883260 | PubTator, text mining | PubMed |
| When the Heart, Kidneys, and Body Waste Away: A Review of Cachexia in Cardiorenal Syndrome. | Curr Heart Fail Rep | 2025 | 40875155 | PubTator, text mining | PubMed |
| Dual functionality of MDM2 in PROTACs expands the horizons of targeted protein degradation. | Biomark Res | 2025 | 40866949 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system dysregulation in FAM111B-related poikiloderma and phenotypic spectrum expansion: new case reports and long-term follow-up. | EBioMedicine | 2025 | 40840166 | PubTator, text mining | PubMed |
| Alpha-Ketoisocaproate Attenuates Muscle Atrophy in Cancer Cachexia Models. | J Cachexia Sarcopenia Muscle | 2025 | 40810552 | PubTator, text mining | PubMed |
| Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening. | ACS Pharmacol Transl Sci | 2025 | 40810141 | PubTator, text mining | PubMed |
| Biotechnology systems engineering: preparing the next generation of bioengineers. | Front Syst Biol | 2025 | 40810124 | PubTator, text mining | PubMed |
| Nutrient restriction protects against valve interstitial cell calcification by upregulating ubiquitin mediated proteolysis. | Front Cardiovasc Med | 2025 | 40761233 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas. | NPJ Precis Oncol | 2025 | 40751074 | PubTator, text mining | PubMed |
| Assessment of the Risk of Failure in Electric Power Supply Systems for Railway Traffic Control Devices. | Sensors (Basel) | 2025 | 40732628 | PubTator, text mining | PubMed |
| Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs. | Commun Chem | 2025 | 40730655 | PubTator, text mining | PubMed |
| Chromatin interaction-based annotation of regulatory elements reveals dynamic promoter-enhancer interactions in lymphocyte development. | iScience | 2025 | 40687796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=5